FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/10/096061 [Registered on: 14/10/2025] Trial Registered Prospectively
Last Modified On: 11/03/2026
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Physiotherapy (Not Including YOGA) 
Study Design  Randomized, Parallel Group, Placebo Controlled Trial 
Public Title of Study   A study to assess the effect of transcranial direct current stimulation with baclofen on muscle tightness and movement in stroke patients  
Scientific Title of Study   Combined Effects of Transcranial Direct Current Stimulation and Oral Baclofen on Spasticity and Motor Function in Patients with Spastic Hemiplegia: A Randomized Controlled Trial 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Raghavendrasingh Dharwadkar 
Designation  MPT ,Assistant Professor, KAHER Institute of Physiotherapy 
Affiliation  KAHER Institute of Physiotherapy 
Address  Department of Neurology Physiotherapy ,Advanced Physiotherapy Center ,Dr Prabhakar Kore Hospital and MRC , Nehru nagar, Belagavi

Belgaum
KARNATAKA
590010
India 
Phone  9886288225  
Fax    
Email  raghavendrasingh@klekipt.edu.in  
 
Details of Contact Person
Scientific Query
 
Name  Dr Raghavendrasingh Dharwadkar 
Designation  MPT ,Assistant Professor, KAHER Institute of Physiotherapy 
Affiliation  KAHER Institute of Physiotherapy 
Address  Department of Neurology Physiotherapy ,Advanced Physiotherapy Center ,Dr Prabhakar Kore Hospital and MRC , Nehru nagar, Belagavi

Belgaum
KARNATAKA
590010
India 
Phone  9886288225  
Fax    
Email  raghavendrasingh@klekipt.edu.in  
 
Details of Contact Person
Public Query
 
Name  Isha shah 
Designation  Post Graduate student  
Affiliation  KAHER Institute of Physiotherapy 
Address  KAHER Institute of Physiotherapy ,J.N.Medical College Campus, Nehru Nagar, Belgaum, Karnataka, India

Belgaum
KARNATAKA
590010
India 
Phone  08329896766  
Fax    
Email  ishashah9979@gmail.com  
 
Source of Monetary or Material Support  
KLEs Dr Prabhakar Kore Hospital and medical research center ,Nehru Nagar, Belagavi , Karnataka , India 590010 
 
Primary Sponsor  
Name  KLE Academy of Higher Education and Research  
Address  KLEs Dr Prabhakar Kore Hospital and medical research center ,Nehru Nagar, Belagavi , Karnataka , India 590010 
Type of Sponsor  Private medical college 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Raghavendrasingh Dharwadkar  KAHER Institute of Physiotherapy   Advanced Physiotherapy Center ,Dr Prabhakar Kore Hospital and MRC , Nehru nagar, Belagavi
Belgaum
KARNATAKA 
9886288225

raghavendrasingh@klekipt.edu.in 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
KLE Academy of Higher Education and Research   Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: G811||Spastic hemiplegia,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Comparator Agent  Sham Transcranial direct current stimulation and Conventional Physiotherapy  The subjects will be given detailed information about the Transcranial direct current stimulation . The sham Transcranial direct current stimulation will be given for 20 minutes , 5 times a week for 2 weeks along with conventional physiotherapy based upon the symptoms such as , stretching, strengthening exercises, roods approach, PNF etc. will be given for 40 minutes after the sham tDCS application. 
Intervention  Transcranial direct current stimulation , oral Baclofen and Conventional physiotherapy  The subjects will be given detailed information about the Transcranial direct current stimulation . The Transcranial direct current stimulation will be given for 20 minutes , 5 times a week for 2 weeks along with Oral Baclofen as prescribed by the consultant neurologist and conventional physiotherapy based upon the symptoms such as stretching, strengthening exercises, roods approach, PNF etc will be given for 40 minutes after the tDCS application. 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  65.00 Year(s)
Gender  Both 
Details  Subjects with :
All genders between the age group of 18 to 65 years of age, Who are willing to participate
Diagnosed with first time stroke Ischemic or Hemorrhagic (more than 3months)
Spasticity more than 1 plus according to Modified Ashworth Scale in atleast one major upper or lower limb muscle.
Consciousness able to follow verbal commands & no hearing disability
No other associated traumatic and non traumatic disorder of neurological, musculoskeletal and cardiac system
 
 
ExclusionCriteria 
Details  Subjects with Severe cognitive impairment
Known Allergy or intolerance to Oral Baclofen drug
Pregnancy or lactation
Sensory disturbances
History of seizures or epilepsy
Presence of metal implants or electronic devices ( eg: pacemaker, cochlear implants)
Currently receiving other spasticity reducing treatment (eg: botulinum toxin , intrathecal baclofen)
Other unstable medical conditions
 
 
Method of Generating Random Sequence   Coin toss, Lottery, toss of dice, shuffling cards etc 
Method of Concealment   Sequentially numbered, sealed, opaque envelopes 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
Modified Ashworth Scale

Fugl meyer assessment Scale
 
Modified Ashworth Scale to assess spasticity pre and post 2 week intervention

Fugl meyer assessment Scale
is used to assess motor function pre and post intervention  
 
Secondary Outcome  
Outcome  TimePoints 
Stroke Impact Scale   Stroke Impact scale assesses physical function , emotion , memory, communication and social participation in stroke survivors pre and post intervention. 
 
Target Sample Size   Total Sample Size="36"
Sample Size from India="36" 
Final Enrollment numbers achieved (Total)= "0"
Final Enrollment numbers achieved (India)="0" 
Phase of Trial   Phase 2 
Date of First Enrollment (India)   15/11/2025 
Date of Study Completion (India) Date Missing 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Date Missing 
Estimated Duration of Trial   Years="1"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)
Modification(s)  
Not Applicable 
Recruitment Status of Trial (India)  Completed 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   This Randomized placebo controlled interventional trail aims to evaluate the combined effect of transcranial direct current stimulation (tDCS) and oral Baclofen on spasticity and motor function in individuals with post -stroke spastic hemiplegia. Stroke is a major cause of long-term disability and spasticity significantly limits functional recovery and quality of life. Participants diagnosed with spastic hemiplegia following stroke will be randomly assigned to two groups. The experimental group will receive real tDCS, oral Baclofen, and conventional physiotherapy, while the control group will receive sham (placebo) tDCS along with conventional physiotherapy. The interventions will be administered over a period of 2 weeks. Primary outcome measures will include changes in spasticity assessed by the Modified Ashworth scale and motor function assessed by the Fugl-Meyer Assessment. Secondary outcomes will include Stroke impact scale. This study intends to investigate whether the combination of non invasive brain stimulation and pharmacological treatment provides superior outcomes compared to physiotherapy alone in managing post stroke spasticity.  
Close